How many shares does LGND own of RTRX? I think it's around 600 thousand. RTRX stock looks strong. LGND gets a 9 % percent royalty on A potential 1 billion product on three parrnership.
When should we expect a update on BRACE from Merck? A big if but if BRACE Is successful LGND should clear 200 per share
Every time I review the next three years I just keep telling myself we are in the early stages of a huge growth curve. 100 PPS is going to happen soon. Wow,,, take a look at the Roth presentation if you haven't yet. It will reinforce your long term outlook.
"based on anecdotal evidence 8931 is showing clinical activity in early/moderate AD."
Could you provide some specifics please? TIA.
Honestly, it took me a while to trust the current management after the clear securities violations and cooking the books with the past CEO. Higgins took over a clearly struggling company he cleaned house ,cut costs ,found a new business model (that is starting to drive significant profits) and is just starting to tip the scales into becoming a well known small cap . It's truly a major turnaround story that Higgins deserves full credit for. The only complaint I have is if the stock gets to the 90 range(soon)a split is clearly going to happen.kryprolis positive p3 is coming in the next 3 months which will yield a long term catalyst for ligand stock. There are so many catalyst in the near term I cannot even remember them all. Good luck longs.
Didn't u sell before earnings? Bad timing we clearing are in a new trading range with the upward breakout possible after the Roth conference. Would like Higgins to split the stock . But the past two years I have no issue with management we are where we should be.
This stock is looking toppy here. I'm out for a while, or I could end up like Taggert cursing -- or praising -- Higgins. (Is it true he now calls Higgins "uncle"? Just asking.)
thanx LV probably why PRAN sold off today or maybe contributing since almost ALL BIO sold off today!
I dipped back into PRAN at 10.25ish net today....I was up $14,559 In Prft and OUT PRAN entirely.....so I said what the hey..lets get back in it gently and see what happens...
Man was I catching my FAVORITE KNIVES today!
"Eisai, Biogen Idec ink collaboration to develop and commercialize Alzheimer’s disease drugs, E2609 & BAN2401"
BACE space is getting interesting, this latest deal is a reflection of increased push for BACE inhibitors. LGND/MRK drug MK8931 is the leader, based on anecdotal evidence 8931 is showing clinical activity in early/moderate AD.
Sentiment: Strong Buy
Historical history, price has significant drop, before next run. Guess were getting near that point for news and takeoff.
Sentiment: Strong Buy